|
Re: Should we not change our name...
|
2
|
Resverlogix Corp.
|
Feb 23, 2019 09:11PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
2
|
Zenith Epigenetics
|
Apr 14, 2022 10:31AM
|
|
Re: Soliciting a loan to shorters
|
2
|
Resverlogix Corp.
|
Jul 26, 2019 01:02PM
|
|
Re: What impact would a PR like this have?
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 09:31AM
|
|
Re: Self Financing
|
2
|
Resverlogix Corp.
|
Apr 02, 2022 07:06AM
|
|
Re: Slow melt-down to topline begins
|
2
|
Resverlogix Corp.
|
May 14, 2019 03:27PM
|
|
Re: Buyout?......
|
2
|
Resverlogix Corp.
|
Jun 02, 2019 08:07PM
|
|
Vaccinex
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 03, 2018 08:51AM
|
|
Re: Morocco compared to Saudi
|
2
|
Resverlogix Corp.
|
Nov 03, 2021 06:59AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 28, 2022 08:48AM
|
|
Re: "we are in now in the hands of the PI's running the trials"
|
2
|
Resverlogix Corp.
|
Oct 21, 2021 06:21PM
|
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 07, 2019 06:26AM
|
|
Re: Hoping we see something significant before June
|
2
|
Resverlogix Corp.
|
Feb 15, 2023 11:25AM
|
|
Zacks
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2021 03:54PM
|
|
Re: Gilead pays $21B for Immunomedics, a single cancer drug (newly approved) for metastic Triple Negative Breast Cancer
|
2
|
Zenith Epigenetics
|
Sep 21, 2020 09:19AM
|
|
Posters sued successfully
|
2
|
Resverlogix Corp.
|
Jan 16, 2020 01:19PM
|
|
Re: RVX LEVEL II
|
2
|
Resverlogix Corp.
|
Aug 14, 2020 02:07PM
|
|
google
|
2
|
Zenith Epigenetics
|
Sep 21, 2020 09:24AM
|
|
Re: Patent Applications in U.S. and Europe
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 05:49AM
|
|
Re: Shrinking MACE event rate
|
2
|
Resverlogix Corp.
|
Jan 20, 2019 06:46AM
|
